Cours Pain Therapeutics, Inc. Nasdaq
Actions
US69562K5065
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | 300 M 274 M | Capitalisation | 966 M 882 M |
---|---|---|---|---|---|
Résultat net 2024 * | -92 M -84,02 M | Résultat net 2025 * | 120 M 110 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 3,22 x |
PER 2024 * |
-11,1
x | PER 2025 * |
13,4
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,82% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01/10/18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01/03/03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07/12/07 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |